Across TCGA pan-cancer cohorts, TMEM35A mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of TMEM35A’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where TMEM35A mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types TMEM35A is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.
COAD, LUAD, and LSCC are the cancer types where TMEM35A tumor–normal differential expression is most reproducible.